Our partner is a biopharmaceutical company dedicated to the development and delivery of immune-based therapies for patients in the US, China, and around the world.

This critical hire reported directly to the Chief Medical Officer. They were responsible for providing strategic and scientific leadership and oversight for all Drug Safety/ Pharmacovigilance and Risk Management activities to ensure proactive and timely benefit-risk assessments of all safety data throughout the lifecycle of our partner's assets from clinical development through post marketing.